Chemoinformaics analysis of Cyclopentanecarboxylic acid, 3-methylene-, 1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester
| Molecular Weight | 262.393 | nRot | 2 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 15 |
| Exact Molecular Weight | 262.193 | nRing | 3 |
| Solubility: LogS | -5.105 | nHRing | 0 |
| Solubility: LogP | 4.249 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 47.3306 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.553 |
| Synth | 4.739 |
| Natural Product Likeliness | 2.294 |
| NR-PPAR-gamma | 0.511 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.634 |
| MDCK | 0.0000231 |
| BBB | 0.97 |
| PPB | 0.803221 |
| VDSS | 1.129 |
| FU | 0.254407 |
| CYP1A2-inh | 0.086 |
| CYP1A2-sub | 0.344 |
| CYP2c19-inh | 0.142 |
| CYP2c19-sub | 0.875 |
| CYP2c9-inh | 0.258 |
| CYP2c9-sub | 0.799 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.894 |
| CYP3a4-inh | 0.442 |
| CYP3a4-sub | 0.229 |
| CL | 9.709 |
| T12 | 0.056 |
| hERG | 0.034 |
| Ames | 0.009 |
| ROA | 0.017 |
| SkinSen | 0.495 |
| Carcinogencity | 0.249 |
| EI | 0.539 |
| Respiratory | 0.869 |
| NR-Aromatase | 0.061 |
| Antiviral | Yes |
| Prediction | 0.647539 |